Validity and Psychometric Properties of 3 and 4 Visual Analog Scale in Participants With Psoriatic Arthritis Treated With Guselkumab
These analyses support the validity of 3VAS/4VAS as multidimensional measures of PsA disease activity. 4VAS may be preferred owing to its greater face validity and separate measurements of the 2 cardinal aspects of PsA (joint/skin disease) and pain.
Authors
- Enrique Roberto Soriano (ORCID: https://orcid.org/0000-0003-3143-1084)
- William Tillett (ORCID: https://orcid.org/0000-0001-7531-4125)
- Peter Nash (ORCID: https://orcid.org/0000-0002-2571-788X)
- Joseph Frank Merola (ORCID: https://orcid.org/0000-0001-6514-4353)
- Marijn Vis (ORCID: https://orcid.org/0000-0002-4402-4165)
- Philip Helliwell (ORCID: https://orcid.org/0000-0002-4155-9105)
- Karissa L. Lozenski (ORCID: https://orcid.org/0009-0009-4031-4067)
- Miriam Zimmermann (ORCID: https://orcid.org/0000-0001-6063-3000)
- Emmanouil Rampakakis (ORCID: https://orcid.org/0000-0002-7427-8246)
- Laura C. Coates (ORCID: https://orcid.org/0000-0002-4756-663X)
- Mohamed Sharaf (ORCID: https://orcid.org/0009-0003-9847-2996)
Institutions
- Griffith University (AU)
- Royal National Hospital for Rheumatic Diseases (GB)
- Johnson & Johnson (United States) (US)
- Chapel Allerton Hospital (GB)
- Nuffield Orthopaedic Centre (GB)
- Hospital Italiano de Buenos Aires (AR)
- Johnson & Johnson (Switzerland) (CH)
- Southwestern Medical Center (US)
- Zimmerman Associates (United States) (US)
- Johnson & Johnson (Israel) (IL)
- McGill University (CA)
- The University of Texas Southwestern Medical Center (US)
- Dubai Pharmacy College (AE)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- The Journal of Rheumatology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.3899/jrheum.2025-0695
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- GlaxoSmithKline
- Celgene
- National Institute for Health and Care Research
- Sun Pharma
- Dutch Arthritis Association